Giant cell arteritis (GCA) and Takayasu's arteritis (TAK) are major forms of large-vessel vasculitis (LVV) that share clinical features. To evaluate their genetic similarities, we analysed Immunochip genotyping data from 1,434 LVV patients and 3,814 unaffected controls. Genetic pleiotropy was also estimated. The HLA region harboured the main disease-specific associations. GCA was mostly associated with class II genes (HLA-DRB1/HLA-DQA1) whereas TAK was mostly associated with class I genes (HLA-B/MICA). Both the statistical significance and effect size of the HLA signals were considerably reduced in the cross-disease meta-analysis in comparison with the analysis of GCA and TAK separately. Consequently, no significant genetic correlation between these two diseases was observed when HLA variants were tested. Outside the HLA region, only one polymorphism located nearby the IL12B gene surpassed the study-wide significance threshold in the meta-analysis of the discovery datasets (rs755374, P = 7.54E-07; OR GCA = 1.19, OR TAK = 1.50). This marker was confirmed as novel GCA risk factor using four additional cohorts (P GCA = 5.52E-04, OR GCA = 1.16). Taken together, our results provide evidence of strong genetic differences between GCA and TAK in the HLA. Outside this region, common susceptibility factors were suggested, especially within the IL12B locus.
Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy / Carmona F.D.; Coit P.; Saruhan-Direskeneli G.; Hernandez-Rodriguez J.; Cid M.C.; Solans R.; Castaneda S.; Vaglio A.; Direskeneli H.; Merkel P.A.; Boiardi L.; Salvarani C.; Gonzalez-Gay M.A.; Martin J.; Sawalha A.H.; Martinez-Berriochoa A.; Unzurrunzaga A.; Hidalgo-Conde A.; Vuelta A.B.; Fernandez-Nebro A.; Ordonez-Canizares M.C.; Fernandez-Gutierrez B.; Rodriguez-Rodriguez L.; Escalante B.; Mari-Alfonso B.; Sopena B.; Gomez-Vaquero C.; Raya E.; Grau E.; Roman J.A.; Vicente E.F.; de Miguel E.; Lopez-Longo F.J.; Martinez L.; Morado I.C.; Diaz-Lopez J.B.; Caminal-Montero L.; Martinez-Zapico A.; Narvaez J.; Monfort J.; Tio L.; Miranda-Filloy J.A.; Sanchez-Martin J.; Alegre-Sancho J.J.; Saez-Comet L.; Perez-Conesa M.; Corbera-Bellalta M.; Ramentol-Sintas M.; Garcia-Villanueva M.J.; Guijarro Rojas M.; Ortego-Centeno N.; Rios Fernandez R.; Callejas J.L.; Sanchez Pernaute O.; Fanlo Mateo P.; Blanco R.; Prieto-Gonzalez S.; Martinez-Taboada V.M.; Soriano A.; Lunardi C.; Gianfreda D.; Santilli D.; Bonatti F.; Muratore F.; Pazzola G.; Addimanda O.; Emmi G.; Ramirez G.A.; Beretta L.; Govoni M.; Cimmino M.A.; Mesut Onat A.; Cefle A.; Yazici A.; Kisacik B.; Dalkilic E.; Seyahi E.; Fresko I.; Tunc E.; Erken E.; Te Ozer H.; Aksu K.; Keser G.; Ozturk M.A.; Bicakcigil M.; Duzgun N.; Karadag O.; Kiraz S.; Pamuk O.N.; Akar S.; Onen F.; Akkoc N.; Kamali S.; Inanc M.; Yentur S.P.; Aydin S.Z.; Alibaz-Oner F.; Kasifoglu T.; Cobankara V.; Ozbalkan Z.; Ates A.; Karaaslan Y.; Carette S.; Chung S.A.; Cuthbertson D.; Forbess L.J.; Hoffman G.S.; Khalidi N.A.; Koening C.L.; Langford C.A.; McAlear C.A.; McKinnon-Maksimowicz K.; Monach PA.; Moreland L.; Pagnoux C.; Seo P.; Spiera R.; Sreih A.G.; Warrington K.J.; Ytterberg S.R.. - In: SCIENTIFIC REPORTS. - ISSN 2045-2322. - ELETTRONICO. - 7:(2017), pp. 1-10. [10.1038/srep43953]
Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy
Vaglio A;Vasculitis Clinical Research Consortium.
2017
Abstract
Giant cell arteritis (GCA) and Takayasu's arteritis (TAK) are major forms of large-vessel vasculitis (LVV) that share clinical features. To evaluate their genetic similarities, we analysed Immunochip genotyping data from 1,434 LVV patients and 3,814 unaffected controls. Genetic pleiotropy was also estimated. The HLA region harboured the main disease-specific associations. GCA was mostly associated with class II genes (HLA-DRB1/HLA-DQA1) whereas TAK was mostly associated with class I genes (HLA-B/MICA). Both the statistical significance and effect size of the HLA signals were considerably reduced in the cross-disease meta-analysis in comparison with the analysis of GCA and TAK separately. Consequently, no significant genetic correlation between these two diseases was observed when HLA variants were tested. Outside the HLA region, only one polymorphism located nearby the IL12B gene surpassed the study-wide significance threshold in the meta-analysis of the discovery datasets (rs755374, P = 7.54E-07; OR GCA = 1.19, OR TAK = 1.50). This marker was confirmed as novel GCA risk factor using four additional cohorts (P GCA = 5.52E-04, OR GCA = 1.16). Taken together, our results provide evidence of strong genetic differences between GCA and TAK in the HLA. Outside this region, common susceptibility factors were suggested, especially within the IL12B locus.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
